Vradenburg George
US Against Alzheimer's (USA2) and Convener of the Global CEO Initiative on Alzheimer's Disease (CEOi), 1101 K Street NW, Suite 400, Washington, DC 20005, US.
Expert Rev Neurother. 2015 Jan;15(1):73-82. doi: 10.1586/14737175.2015.995638.
The world is at a pivotal moment in the global fight against Alzheimer's disease, a disease that by 2013 affected 44.4 million people globally and is expected to affect 75.6 million by 2030. France, Australia, Japan, US and Great Britain are among the countries that have adopted national policies to address the growing numbers. Multilateral organizations have also prioritized the disease, and possibly most significantly, the G8, under British Prime Minister David Cameron's leadership, set its focus on dementia starting December 2013. Despite the growing attention, the response has not been commensurate with the urgency of the situation, and we need to promote comprehensive collaboration that catalyzes the development of new treatments, initiates the creation of innovative financial models for research and drives the utilization of technological innovation with the aim to reverse the trajectory of this devastating disease.
世界正处于全球抗击阿尔茨海默病的关键节点，到2013年，这种疾病在全球影响了4440万人，预计到2030年将影响7560万人。法国、澳大利亚、日本、美国和英国等国家已制定国家政策来应对这一不断增长的数字。多边组织也将该疾病列为优先事项，或许最重要的是，在英国首相戴维·卡梅伦的领导下，八国集团自2013年12月起将重点放在痴呆症上。尽管关注度不断提高，但应对措施与形势的紧迫性并不相称，我们需要推动全面合作，以促进新疗法的开发，开创创新的研究融资模式，并推动技术创新的应用，旨在扭转这种毁灭性疾病的发展趋势。
